Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs MyStart Health

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and MyStart Health head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 150 · Grade C

MyStart Health

Visit MyStart Health Full brief →

FDA warning letter, September 2025 — issued to Matthew Stern, CEO MyStart Health LLC.. See the FDA's warning letter database.

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 71 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make MyStart Health a bad call — it's best for readers who want continuing clinical access and can confirm the named medication, payment cycle and cancellation cutoff before enrolling. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
78
Supply Reliability
95
78
Transparency
90
72
Access Breadth
93
56
Clinical Oversight
92
85
Track Record
88
51
CoreAge RxBrief Score 94 · 71MyStart Health

Price, coverage & the tracker

CoreAge RxMyStart Health
Brief Score94/100 (A)71/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

Confirm a named-drug quote

Generic program starts at $299/mo; a current semaglutide quote is not established. Automatic billing depends on the selected plan.

Full price details

Current named semaglutide offer and complete quote unknown; generic program starts $299/month; earlier listing: From $299/mo (all doses, compounded)

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

Confirm a named-drug quote

Generic program starts at $299/mo; a current tirzepatide quote is not established. Automatic billing depends on the selected plan.

Full price details

Current named tirzepatide offer and complete quote unknown; generic program starts $299/month; earlier listing: From $299/mo (all doses, compounded)

CoverageUS only; restrictions by state, confirmed at intakeCurrent medication-specific state availability requires confirmation; reviewed public pages did not establish a complete service roster
Brand-name accessNot confirmedNot confirmed
Oral / sublingualInjection onlyYes
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

MyStart Health: The current program starts at $299/month before discounts, without verified separate medication quotes. Monthly or quarterly automatic billing depends on the selected plan.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.